Parallel to this, SIRT1 suppression in the mouse liver is sufficient to cause hepatic steatosis [83], an effect that may be mediated via Ppar-γ and Pparα, the key regulators of glycolysis and lipolysis [80,84]. Here, SIRT1 is linked to fatty liver disease.